Financial Gravity Asset Management’s Edwards Lifesciences EW Stock Holding History

Financial Gravity Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$961	Buy	+12	New	+$989	﹤0.01%	759
2025 Q1	$870	Buy	+12	New	+$859	﹤0.01%	889
2024 Q1	–	Sell	-2	Closed	-$186	–	1237
2023 Q4	$186	Buy	+2	New	+$139	﹤0.01%	1050
2021 Q3	$113K	Buy	+2	New	+$228	0.05%	318
2020 Q4	$0	Buy	+4	New	+$332	﹤0.01%	532
2019 Q4	$233K	Hold	315	–	–	0.16%	92
2019 Q3	$23K	Buy	315 +240	+320%	+$16.9K	0.02%	431
2019 Q2	$5K	Sell	75 -9	-11%	-$544	﹤0.01%	684
2019 Q1	$5K	Buy	+84	New	+$4.79K	﹤0.01%	677
2018 Q3	$52K	Buy	1,131 +924	+446%	+$45.2K	0.05%	308
2018 Q2	$9K	Sell	207 -57	-22%	-$2.66K	0.01%	586
2018 Q1	$12K	Buy	+264	New	+$11.5K	0.01%	562

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Financial Gravity Asset Management's EW Position: Q1 2026 in Review

Financial Gravity Asset Management opened a new position in Edwards Lifesciences (EW) in Q1 2026: 12 shares worth $961. The stake represents ﹤0.01% of the portfolio and ranks #759 among its holdings. This is a return to the name: Financial Gravity Asset Management previously reported a position in EW as recently as Q1 2025.

Financial Gravity Asset Management first reported a position in EW in Q1 2018 and has held it in 12 quarters since. The position peaked at $233K in Q4 2019. 1,292 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Financial Gravity Asset Management held 12 shares of Edwards Lifesciences worth $961 as of Q1 2026.
Edwards Lifesciences was a new Financial Gravity Asset Management position in Q1 2026.
Edwards Lifesciences made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2026, its #759 holding.
Financial Gravity Asset Management first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 12 quarters since.
Financial Gravity Asset Management's Edwards Lifesciences position peaked at $233K in Q4 2019.
1,292 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.